| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0006-5331-01 | 0006-5331 | HUMAN PRESCRIPTION DRUG | WELIREG | belzutifan | TABLET, FILM COATED | ORAL | 20210813 | N/A | NDA | NDA215383 | Merck Sharp & Dohme LLC | BELZUTIFAN | 40 mg/1 | 90 TABLET, FILM COATED in 1 BOTTLE (0006-5331-01) |
| 0006-5331-58 | 0006-5331 | HUMAN PRESCRIPTION DRUG | WELIREG | belzutifan | TABLET, FILM COATED | ORAL | 20230621 | N/A | NDA | NDA215383 | Merck Sharp & Dohme LLC | BELZUTIFAN | 40 mg/1 | 1 BOTTLE in 1 CARTON (0006-5331-58) / 90 TABLET, FILM COATED in 1 BOTTLE |
| 0006-5331-59 | 0006-5331 | HUMAN PRESCRIPTION DRUG | WELIREG | belzutifan | TABLET, FILM COATED | ORAL | 20230621 | N/A | NDA | NDA215383 | Merck Sharp & Dohme LLC | BELZUTIFAN | 40 mg/1 | 1 BOTTLE in 1 CARTON (0006-5331-59) / 90 TABLET, FILM COATED in 1 BOTTLE |